Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05362409 · ClinicalTrials.gov registry record · Phase 1

Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma

A Phase 1 study of High Grade Glioma, sponsored by Alpheus Medical.

Completed
Registry status
Phase 1
Development phase
22
Enrollment target
3
Study locations

NCT05362409 is a Phase 1 study of High Grade Glioma that has completed, run by Alpheus Medical. The registered enrollment target is 22 participants, below the 65-participant average among 42 other High Grade Glioma trials with a reported enrollment target (66% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05362409, a Phase 1 study of High Grade Glioma, has completed, sponsored by Alpheus Medical.

COMPLETED
Registry status
Phase 1
Development phase
22 participants
Enrollment target
3
Study locations

Study Summary

A Phase 1 Multi-center clinical Trial Evaluating the Safety and Tolerability of 5-aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With recurrent High Grade Glioma (HGG).

Conditions Studied

High Grade Glioma

Interventions

  • DRUG 5 Aminolevulinic Acid
  • DEVICE CV01-delivered ultrasound

Study Locations (3)

New York

  • Dent Neurosciences Research Center - Amherst
  • Northwell - Lake Success

Missouri

  • Washington University School of Medicine in St.Louis - St Louis

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2022-06-29
Est. Completion 2025-02-03
Phase Phase 1

Sponsor

Alpheus Medical

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05362409

The ClinicalTrials.gov registry entry for NCT05362409 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 65-participant average among 42 other High Grade Glioma trials with a reported enrollment target (66% lower). The listed sponsor is Alpheus Medical, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with High Grade Glioma appearing as the primary indexed condition, and to 2 interventions - of which 5 Aminolevulinic Acid is the first listed.

NCT05362409 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, Missouri.

Frequently Asked Questions

What is clinical trial NCT05362409 about?

NCT05362409 is a clinical study titled "Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma". A Phase 1 Multi-center clinical Trial Evaluating the Safety and Tolerability of 5-aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With recurrent High Grade Glioma (HGG).

What is the current status of trial NCT05362409?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2022-06-29. Estimated completion is 2025-02-03.

What conditions does trial NCT05362409 study?

This clinical trial studies the following conditions: High Grade Glioma.

What interventions are being tested in trial NCT05362409?

The interventions under investigation include: 5 Aminolevulinic Acid (DRUG), CV01-delivered ultrasound (DEVICE).

Who is sponsoring clinical trial NCT05362409?

This trial is sponsored by Alpheus Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05362409 being conducted?

This trial has 3 study locations across Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for High Grade Glioma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

High Grade Glioma

All registered trials for this condition

Missouri

All trials with a study site in Missouri

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.